β2-adrenoceptor agonists can both stimulate and inhibit glucose uptake in mouse soleus muscle through ligand-directed signalling

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 386, Issue 9, 2013, Pages 761-773

  Ngala, Robert A ^a,b   O'Dowd, Jacqueline F ^b   Stocker, Claire J ^b   Cawthorne, Michael A ^b   Arch, Jonathan R S ^b  

^a KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

^b UNIVERSITY OF BUCKINGHAM   (United Kingdom)

Author keywords

2 adrenoceptor; BRL37344; Clenbuterol; Glucose uptake; Ligand directed signalling; Soleus muscle

Indexed keywords

4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID; ADRENALIN; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CLENBUTEROL; CYCLIC AMP; FORSKOLIN; GLUCOSE; PERTUSSIS TOXIN; ROLIPRAM;

ANIMAL TISSUE; ARTICLE; DRUG EFFECT; GLUCOSE TRANSPORT; MOUSE; NONHUMAN; SOLEUS MUSCLE;

ADRENERGIC BETA-2 RECEPTOR AGONISTS; ANIMALS; CLENBUTEROL; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; EPINEPHRINE; ETHANOLAMINES; GLUCOSE; LIGANDS; MALE; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHATIDYLINOSITOL 3-KINASES; SIGNAL TRANSDUCTION;

EID: 84883232108     PISSN: 00281298     EISSN: 14321912     Source Type: Journal    
DOI: 10.1007/s00210-013-0860-5     Document Type: Article

References (81)

1. 3- adrenergic agonist, BRL 35135A, on glucose uptake in rat skeletal muscle in vivo and in vitro. J Endocrinol 139:479-486
2. Arcaro A, Wymann MP (1993) Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses. Biochem J 296(Pt 2):297-301
3. Aslesen R, Jensen J (1998) Effects of epinephrine on glucose metabolism in contracting rat skeletal muscles. Am J Physiol 275:E448-456
4. 2-adrenoceptor provide evidence for agonist-directed signaling. Mol Pharmacol 64:1357-1369
5. Baker JG, Hill SJ (2007) Multiple GPCR conformations and signalling pathways: implications for antagonist affinity estimates. Trends Pharmacol Sci 28:374-381
6. Blanco-Rivero J, Aras-Lopez R, Del Campo L, Sagredo A, Balfagon G, Ferrer M (2006) Orchidectomy increases β-adrenoceptor activation-mediated neuronal nitric oxide and noradrenaline release in rat mesenteric artery. Neuroendocrinology 84:378-385
7. Board M, Doyle P, Cawthorne MA (2000) BRL37344, but not CGP12177, stimulates fuel oxidation by soleus muscle in vitro. Eur J Pharmacol 406:33-40
8. 3-adrenoceptor-induced eNOS activation in right atrial and left ventricular human myocardium. Br J Pharmacol 143:1014-1022
9. Brunn GJ, Williams J, Sabers C, Wiederrecht G, Lawrence JC Jr, Abraham RT (1996) Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002. EMBO J 15:5256-5267
10. Buhl ES, Jessen N, Schmitz O, Pedersen SB, Pedersen O, Holman GD, Lund S (2001) Chronic treatment with 5-aminoimidazole-4-carboxamide-1-β-D- ribofuranoside increases insulin-stimulated glucose uptake and GLUT4 translocation in rat skeletal muscles in a fiber type-specific manner. Diabetes 50:12-17
11. 3- adrenergic receptor agonists and is involved in a cyclic AMP-dependent lipolysis in adipocytes. Nitric Oxide 14:200-211
12. Chambers MA, Moylan JS, Smith JD, Goodyear LJ, Reid MB (2009) Stretch-stimulated glucose uptake in skeletal muscle is mediated by reactive oxygen species and p38 MAP-kinase. J Physiol 587:3363-3373
13. Cheng HC, Kemp BE, Pearson RB, Smith AJ, Misconi L, Van Patten SM, Walsh DA (1986) A potent synthetic peptide inhibitor of the cAMP-dependent protein kinase. J Biol Chem 261:989-992
14. 3-adrenoceptors through a cAMP, PKA, and PI3-kinase-dependent pathway stimulating conventional and novel PKCs. Endocrinology 145:269-280
15. Chiasson JL, Shikama H, Chu DT, Exton JH (1981) Inhibitory effect of epinephrine on insulin-stimulated glucose uptake by rat skeletal muscle. J Clin Invest 68:706-713
16. 2-adrenergic signaling to AKT: role of Gi and SRC. Cell Signal 19:1949-1955
17. Cool B, Zinker B, Chiou W, Kifle L, Cao N, Perham M, Dickinson R, Adler A, Gagne G, Iyengar R, Zhao G, Marsh K, Kym P, Jung P, Camp HS, Frevert E (2006) Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome. Cell Metab 3:403-416
18. 2-adrenergic receptor to different G proteins by protein kinase A. Nature 390:88-91
19. Davies SP, Reddy H, Caivano M, Cohen P (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351:95-105
20. 2- Adrenoceptors increase translocation of GLUT4 via GPCR kinase sites in the receptor C-terminal tail. Br J Pharmacol 165:1442-1456
21. Elmendorf JS, Damrau-Abney A, Smith TR, David TS, Turinsky J (1995) Insulin-stimulated phosphatidylinositol 3-kinase activity and 2-deoxy-D-glucose uptake in rat skeletal muscles. Biochem Biophys Res Commun 208:1147-1153
22. Evans BA, Sato M, Sarwar M, Hutchinson DS, Summers RJ (2010) Ligand-directed signalling at β-adrenoceptors. Br J Pharmacol 159:1022-1038
23. Fediuc S, Gaidhu MP, Ceddia RB (2006) Inhibition of insulin-stimulated glycogen synthesis by 5-aminoimidasole-4-carboxamide-1-β-d-ribofuranoside- induced adenosine 5′-monophosphate-activated protein kinase activation: interactions with Akt, glycogen synthase kinase 3-3α/β, and glycogen synthase in isolated rat soleus muscle. Endocrinology 147:5170-5177
24. Figueira ME, do Vale FM, Barroso MI, Rico JM, Castro M (1998) Dietary β-adrenoceptor agonists have a persistent effect on nitric oxide synthesis in rat cultured smooth muscle cells. Eur J Pharmacol 362:261-266
25. Fluckey JD, Knox M, Smith L, Dupont-Versteegden EE, Gaddy D, Tesch PA, Peterson CA (2006) Insulin-facilitated increase of muscle protein synthesis after resistance exercise involves a MAP kinase pathway. Am J Physiol Endocrinol Metab 290:E1205-1211
26. Frost RA, Nystrom GJ, Lang CH (2004) Epinephrine stimulates IL-6 expression in skeletal muscle and C2C12 myoblasts: role of c-Jun NH2-terminal kinase and histone deacetylase activity. Am J Physiol Endocrinol Metab 286:E809-817
27. Fujishiro M, Gotoh Y, Katagiri H, Sakoda H, Ogihara T, Anai M, Onishi Y, Ono H, Funaki M, Inukai K, Fukushima Y, Kikuchi M, Oka Y, Asano T (2001) MKK6/3 and p38 MAPK pathway activation is not necessary for insulin-induced glucose uptake but regulates glucose transporter expression. J Biol Chem 276:19800-19806
28. 2 adrenergic receptor ligands toward adenylyl cyclase and mitogen-activated protein kinase reveals the pluridimensionality of efficacy. Mol Pharmacol 70:1575-1584
29. 3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle. J Clin Invest 102:1377-1384
30. Gosmanov AR, Nordtvedt NC, Brown R, Thomason DB (2002) Exercise effects on muscle β-adrenergic signaling for MAPK-dependent NKCC activity are rapid and persistent. J Appl Physiol 93:1457-1465
31. Gosmanov AR, Thomason DB (2002) Insulin and isoproterenol differentially regulate mitogen-activated protein kinase-dependent Na(+)-K(+)-2Cl(-) cotransporter activity in skeletal muscle. Diabetes 51:615-623
32. 2-adrenoceptors overexpressed in mouse heart. Mol Pharmacol 65:1313-1322
33. Higaki Y, Mikami T, Fujii N, Hirshman MF, Koyama K, Seino T, Tanaka K, Goodyear LJ (2008) Oxidative stress stimulates skeletal muscle glucose uptake through a phosphatidylinositol 3-kinase-dependent pathway. Am J Physiol Endocrinol Metab 294:E889-897
34. 1- adrenoceptors causing glucose uptake. Diabetes 55:682-690
35. 3b-adrenoceptors expressed in Chinese hamster ovary cells display identical pharmacology but utilize distinct signalling pathways. Br J Pharmacol 135:1903-1914
36. Hutchinson DS, Chernogubova E, Dallner OS, Cannon B, Bengtsson T (2005a) β-adrenoceptors, but not α-adrenoceptors, stimulate AMP-activated protein kinase in brown adipocytes independently of uncoupling protein-1. Diabetologia 48:2386-2395
37. Hutchinson DS, Sato M, Evans BA, Christopoulos A, Summers RJ (2005b) Evidence for pleiotropic signaling at the mouse β3-adrenoceptor revealed by SR59230A [3-(2-Ethylphenoxy)-1-[(1, S)-1,2,3,4-tetrahydronapth-1-ylamino]-2S-2- propa nol oxalate]. J Pharmacol Exp Ther 312:1064-1074
38. 2-adrenergic stimulation. Circ Res 91:46-53
39. Jorgensen SB, Honeyman J, Oakhill JS, Fazakerley D, Stockli J, Kemp BE, Steinberg GR (2009) Oligomeric resistin impairs insulin and AICAR-stimulated glucose uptake in mouse skeletal muscle by inhibiting GLUT4 translocation. Am J Physiol Endocrinol Metab 297:E57-66
40. 2-adrenergic receptor. Nat Chem Biol 7:692-700
41. Kanda Y, Watanabe Y (2007) Adrenaline increases glucose transport via a Rap1-p38MAPK pathway in rat vascular smooth muscle cells. Br J Pharmacol 151:476-482
42. Kapur S, Bedard S, Marcotte B, Cote CH, Marette A (1997) Expression of nitric oxide synthase in skeletal muscle: a novel role for nitric oxide as a modulator of insulin action. Diabetes 46:1691-1700
43. Kaushik VK, Young ME, Dean DJ, Kurowski TG, Saha AK, Ruderman NB (2001) Regulation of fatty acid oxidation and glucose metabolism in rat soleus muscle: effects of AICAR. Am J Physiol Endocrinol Metab 281:E335-340
44. Kenakin T (1995) Agonist-receptor efficacy II: agonist trafficking of receptor signals. Trends Pharmacol Sci 16:232-238
45. Kong D, Dan S, Yamazaki K, Yamori T (2010) Inhibition profiles of phosphatidylinositol 3-kinase inhibitors against PI3K superfamily and human cancer cell line panel JFCR39. Eur J Cancer 46:1111-1121
46. Lazar S, Galiani D, Dekel N (2002) cAMP-Dependent PKA negatively regulates polyadenylation of c-mos mRNA in rat oocytes. Mol Endocrinol 16:331-341
47. Leblais V, Jo SH, Chakir K, Maltsev V, Zheng M, Crow MT, Wang W, Lakatta EG, Xiao RP (2004) Phosphatidylinositol 3-kinase offsets cAMP-mediated positive inotropic effect via inhibiting Ca2+ influx in cardiomyocytes. Circ Res 95:1183-1190
48. Liu YL, Cawthorne MA, Stock MJ (1996) Biphasic effects of the β-adrenoceptor agonist, BRL 37344, on glucose utilization in rat isolated skeletal muscle. Br J Pharmacol 117:1355-1361
49. Lu ZX, Quazi NH, Deady LW, Polya GM (1996) Selective inhibition of cyclic AMP-dependent protein kinase by isoquinoline derivatives. Biol Chem Hoppe Seyler 377:373-384
50. 2-adrenergic receptor-induced regulation of p38 mitogen-activated protein kinase in B lymphocytes. Mol Cell Biol 29:675-686
51. McConell GK, Wadley GD (2008) Potential role of nitric oxide in contraction-stimulated glucose uptake and mitochondrial biogenesis in skeletal muscle. Clin Exp Pharmacol Physiol 35:1488-1492
52. McGrowder D, Ragoobirsingh D, Brown P (2006) Acute effects of exogenous nitric oxide on glucose uptake in skeletal muscle of normoglycaemic and diabetic rats. Med Sci Monit 12:BR28-35
53. 3-adrenoceptors. Br J Pharmacol 149:635-646
54. Nesher R, Karl IE, Kipnis DM (1980) Epitrochlearis muscle. II. Metabolic effects of contraction and catecholamines. Am J Physiol 239:E461-467
55. 2-adrenoceptor-mediated glucose uptake in rat skeletal muscle cells. Br J Pharmacol 147:446-454
56. 2- adrenoceptor mechanisms. Br J Pharmacol 155:395-406
57. 2-Adrenoceptors and non- β-adrenoceptors mediate effects of BRL37344 and clenbuterol on glucose uptake in soleus muscle: studies using knockout mice. Br J Pharmacol 158(7):1676-82
58. Nishitani S, Matsumura T, Fujitani S, Sonaka I, Miura Y, Yagasaki K (2002) Leucine promotes glucose uptake in skeletal muscles of rats. Biochem Biophys Res Commun 299:693-696
59. Niu W, Bilan PJ, Hayashi M, Da Y, Yao Z (2007) Insulin sensitivity and inhibition by forskolin, dipyridamole and pentobarbital of glucose transport in three L6 muscle cell lines. Sci China C Life Sci 50:739-747
60. 3- adrenoceptors. Eur J Pharmacol 348:53-60
61. Robidoux J, Martin TL, Collins S (2004) β-adrenergic receptors and regulation of energy expenditure: a family affair. Annu Rev Pharmacol Toxicol 44:297-323
62. Roy D, Perreault M, Marette A (1998) Insulin stimulation of glucose uptake in skeletal muscles and adipose tissues in vivo is NO dependent. Am J Physiol 274:E692-699
63. 3-adrenoceptor produced by 3-(2-Ethylphenoxy)-1-[(1, S)-1,2,3,4-tetrahydronapth-1-ylamino]-2S-2-propan ol oxalate (SR59230A) relative to receptor agonists. Mol Pharmacol 72:1359-1368
64. Siedlecka U, Arora M, Kolettis T, Soppa GK, Lee J, Stagg MA, Harding SE, Yacoub MH, Terracciano CM (2008) Effects of clenbuterol on contractility and Ca2+ homeostasis of isolated rat ventricular myocytes. Am J Physiol Heart Circ Physiol 295:H1917-1926
65. Stocker CJ, Wargent E, O'Dowd J, Cornick C, Speakman JR, Arch JR, Cawthorne MA (2007) Prevention of diet-induced obesity and impaired glucose tolerance in rats following administration of leptin to their mothers. Am J Physiol Regul Integr Comp Physiol 292:R1810-1818
66. Vincent MA, Barrett EJ, Lindner JR, Clark MG, Rattigan S (2003) Inhibiting NOS blocks microvascular recruitment and blunts muscle glucose uptake in response to insulin. Am J Physiol Endocrinol Metab 285:E123-129
67. Vlahos CJ, Matter WF, Hui KY, Brown RF (1994) A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 269:5241-5248
68. Wallberg-Henriksson H (1987) Glucose transport into skeletal muscle. Influence of contractile activity, insulin, catecholamines and diabetes mellitus. Acta Physiologica Scand Suppl 564:1-80
69. Wang S, Subramaniam A, Cawthorne MA, Clapham JC (2003) Increased fatty acid oxidation in transgenic mice overexpressing UCP3 in skeletal muscle. Diabetes Obes Metab 5:295-301
70. 2-adrenoceptor signaling is dictated by GRK2 phosphorylation in cardiomyocytes. J Biol Chem 283:1799-1807
71. Wojtaszewski JF, Hansen BF, Urso B, Richter EA (1996) Wortmannin inhibits both insulin- and contraction-stimulated glucose uptake and transport in rat skeletal muscle. J Appl Physiol 81:1501-1509
72. Wong JA, Gosmanov AR, Schneider EG, Thomason DB (2001) Insulin-independent, MAPK-dependent stimulation of NKCC activity in skeletal muscle. Am J Physiol Regul Integr Comp Physiol 281:R561-571
73. 2-adrenoceptor is essential for physiologic signaling and trafficking in cardiac myocytes. Proc Natl Acad Sci U S A 100:10776-10781
74. 2-adrenoceptor to Gi proteins and its physiological relevance in murine cardiac myocytes. Circ Res 84:43-52
75. 2- Adrenergic activation increases glycogen synthesis in L6 skeletal muscle cells through a signalling pathway independent of cyclic AMP. Diabetologia 50:158-167
76. Yano N, Ianus V, Zhao TC, Tseng A, Padbury JF, Tseng YT (2007) A novel signaling pathway for β-adrenergic receptor-mediated activation of phosphoinositide 3-kinase in H9c2 cardiomyocytes. Am J Physiol Heart Circ Physiol 293:H385-393
77. Yeh JI, Gulve EA, Rameh L, Birnbaum MJ (1995) The effects of wortmannin on rat skeletal muscle. Dissociation of signaling pathways for insulin- and contraction-activated hexose transport. J Biol Chem 270:2107-2111
78. Young DA, Wallberg-Henriksson H, Cranshaw J, Chen M, Holloszy JO (1985) Effect of catecholamines on glucose uptake and glycogenolysis in rat skeletal muscle. Am J Physiol 248:C406-409
79. Young ME, Radda GK, Leighton B (1996) Activation of glycogen phosphorylase and glycogenolysis in rat skeletal muscle by AICAR - an activator of AMP-activated protein kinase. FEBS Lett 382:43-47
80. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirshman MF, Goodyear LJ, Moller DE (2001) Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108:1167-1174
81. Zhou G, Sebhat IK, Zhang BB (2009) AMPK activators - potential therapeutics for metabolic and other diseases. Acta Physiol (Oxf) 196:175-190